Martin Michael Robert

Track

Insider profile

Martin Michael Robert's trades of Aurinia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-09 2022-11-07
B Purchase
51,914 +20.5%
402.04
US$619,368 		51,914 +20.5% 402.04 US$619,368
2022-03-04 2022-03-02
S Sale
46,265 -44.4%
49.92
US$3,972,741 		46,265 -44.4% 49.92 US$3,972,741
2021-11-12 2021-11-11
PlS Planned sale
25,199 +23.3%
478.89
US$4,132,281 		25,199 +23.3% 478.89 US$4,132,281
2021-11-12 2021-11-11
PlS Planned sale
29,000 -30.3%
28.82
US$835,780 		29,000 -30.3% 28.82 US$835,780
2021-11-12 2021-11-10
PlS Planned sale
10,000 -13.0%
30.55
US$305,500 		10,000 -13.0% 30.55 US$305,500
2021-11-12 2021-11-10
PlS Planned sale
50,000 -39.4%
31.26
US$1,563,000 		50,000 -39.4% 31.26 US$1,563,000
2021-11-12 2021-11-09
PlS Planned sale
50,000 -28.3%
30.17
US$1,508,500 		50,000 -28.3% 30.17 US$1,508,500
2021-11-03 2021-11-01
PlS Planned sale
45,000 -20.3%
31.64
US$1,423,800 		45,000 -20.3% 31.64 US$1,423,800
2021-09-14 2021-09-14
PlS Planned sale
90,000 -33.7%
21.19
US$1,907,217 		90,000 -33.7% 21.19 US$1,907,217
2021-09-14 2021-09-10
PlS Planned sale
25,000 -12.4%
19.80
US$495,000 		25,000 -12.4% 19.80 US$495,000
2021-06-23 2021-06-22
PlS Planned sale
5,000 -2.3%
13.76
US$68,800 		5,000 -2.3% 13.76 US$68,800